Kevin McCarthy
Former House Speaker
Lynette Byrd
Former Assistant
U.S. Attorney
John Sellers
Former DOJ
U.S. Attorney
Michele A. Ratcliffe
Former Assistant U.S. Attorney
Dr. Nick Oberheiden
Attorney & Founder
DOJ Targets Black Market Prescription Drug Diversion, Signaling Possible New Enforcement Trend
Over the past year the U.S. Department of Justice (DOJ) has publicized two criminal enforcement cases targeting black market prescription drug diversion. In these cases, the DOJ targeted pharmacists, pharmaceutical distributors and sales representatives, and their associates—charging them with knowingly providing prescription medications for non-medical use to third parties for...
Read more
25 Key Facts about Federal Drug Diversion Investigations
Facing a federal drug diversion investigation is an extremely serious matter. If you have received a target letter or subpoena, or if any employee of your business or practice has been contacted by a federal agent, here are 25 key facts you need to know: 1. Combatting Drug Diversion (and...
Read more